Banyoles, Spain

Rafael De Llorens Duran

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rafael De Llorens Duran. Retrieved from https://idiyas.com/inventor/rafael-de-llorens-duran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rafael De Llorens Duran: Innovator in Antitumor Agents

Introduction

Rafael De Llorens Duran is a notable inventor based in Banyoles, Spain. He has made significant contributions to the field of biochemistry, particularly in the development of antitumor agents. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

Rafael holds a patent for "Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents." This invention focuses on metalocarboxypeptidase inhibitors and their natural protein variants or engineered protein variants. Additionally, it includes peptidomimetic molecules derived from these inhibitors, which are utilized as antitumor agents. This patent represents a significant advancement in cancer treatment methodologies.

Career Highlights

Throughout his career, Rafael has demonstrated a commitment to research and innovation. His work has not only contributed to scientific knowledge but also has practical applications in medicine. With a total of 1 patent, he has established himself as a key figure in his field.

Collaborations

Rafael has collaborated with esteemed colleagues, including Carmen Blanco Aparicio and Miguel Angel Molina Vila. These partnerships have enhanced his research efforts and contributed to the success of his projects.

Conclusion

Rafael De Llorens Duran is a distinguished inventor whose work in developing antitumor agents showcases his dedication to advancing medical science. His innovative contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…